82 related articles for article (PubMed ID: 33355644)
21. Commentary: 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration.
Prieto PA
J Clin Aesthet Dermatol; 2023 Dec; 16(12 Suppl 1):S9-S11. PubMed ID: 38125000
[No Abstract] [Full Text] [Related]
22. Skin lesions of face and scalp - Classification by a market-approved convolutional neural network in comparison with 64 dermatologists.
Haenssle HA; Winkler JK; Fink C; Toberer F; Enk A; Stolz W; Deinlein T; Hofmann-Wellenhof R; Kittler H; Tschandl P; Rosendahl C; Lallas A; Blum A; Abassi MS; Thomas L; Tromme I; Rosenberger A;
Eur J Cancer; 2021 Feb; 144():192-199. PubMed ID: 33370644
[TBL] [Abstract][Full Text] [Related]
23. Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.
Turiello R; Capone M; Giannarelli D; Morretta E; Monti MC; Madonna G; Mallardo D; Festino L; Azzaro R; Levesque MP; Imhof L; Weide B; Amaral T; Chevrier M; Sucker A; Rutkowski P; Schadendorf D; Lebbe C; Luke JJ; Wistuba-Hamprecht K; Dummer R; Pinto A; Morello S; Ascierto PA
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33361405
[TBL] [Abstract][Full Text] [Related]
24. The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies.
Varghese S; Pramanik S; Williams LJ; Hodges HR; Hudgens CW; Fischer GM; Luo CK; Knighton B; Tan L; Lorenzi PL; Mackinnon AL; McQuade JL; Hailemichael Y; Roszik J; Peng W; Vashisht Gopal YN
Mol Cancer Ther; 2021 Mar; 20(3):500-511. PubMed ID: 33361272
[TBL] [Abstract][Full Text] [Related]
25. MONTHLY INTRAVITREAL INFLIXIMAB IN BEHÇET'S DISEASE ACTIVE POSTERIOR UVEITIS: A Long-Term Safety Study.
Refaat M; Abdullatif AM; Hamza MM; Macky TA; El-Agha MH; Ragab G; Soliman MM
Retina; 2021 Aug; 41(8):1739-1747. PubMed ID: 33394998
[TBL] [Abstract][Full Text] [Related]
26. Estimation of the timing of BAP1 mutation in uveal melanoma progression.
Uner OE; See TRO; Szalai E; Grossniklaus HE; Stålhammar G
Sci Rep; 2021 Apr; 11(1):8923. PubMed ID: 33903674
[TBL] [Abstract][Full Text] [Related]
27. The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics.
Giblin W; Bringman-Rodenbarger L; Guo AH; Kumar S; Monovich AC; Mostafa AM; Skinner ME; Azar M; Mady AS; Chung CH; Kadambi N; Melong KA; Lee HJ; Zhang L; Sajjakulnukit P; Trefely S; Varner EL; Iyer S; Wang M; Wilmott JS; Soyer HP; Sturm RA; Pritchard AL; Andea AA; Scolyer RA; Stark MS; Scott DA; Fullen DR; Bosenberg MW; Chandrasekaran S; Nikolovska-Coleska Z; Verhaegen ME; Snyder NW; Rivera MN; Osterman AL; Lyssiotis CA; Lombard DB
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33945506
[TBL] [Abstract][Full Text] [Related]
28. Circulating Tumor DNA Reflects Uveal Melanoma Responses to Protein Kinase C Inhibition.
Park JJ; Diefenbach RJ; Byrne N; Long GV; Scolyer RA; Gray ES; Carlino MS; Rizos H
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917514
[TBL] [Abstract][Full Text] [Related]
29. Systemic and liver-directed therapies in metastatic uveal melanoma: state-of-the-art and novel perspectives.
Comito F; Marchese PV; Ricci AD; Tober N; Peterle C; Sperandi F; Melotti B
Future Oncol; 2021 Nov; 17(33):4583-4606. PubMed ID: 34431316
[TBL] [Abstract][Full Text] [Related]
30. Hax-1 Regulates Radiation-Induced Mitochondrial-Dependent Apoptosis of Uveal Melanoma Cells through PI3K/AKT/eNOS Pathway.
Wang S; Tan J; Chen L; Wang J
J Oncol; 2022; 2022():2956888. PubMed ID: 35602302
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.
Zhao S; Jiang H; Liu J; Li DY; Li B; Long QR; Zheng L; Gu H
Dis Markers; 2022; 2022():5994800. PubMed ID: 35251374
[TBL] [Abstract][Full Text] [Related]
32. Small Choroidal Melanoma: Correlation between Clinical Characteristics and Metastatic Potential.
Luo S; Raval V; Zabor EC; Singh AD
Ocul Oncol Pathol; 2021 Dec; 7(6):437-446. PubMed ID: 35087820
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma.
Onken MD; Noda SE; Kaltenbronn KM; Frankfater C; Makepeace CM; Fettig N; Piggott KD; Custer PL; Ippolito JE; Blumer KJ
J Biol Chem; 2022 Jan; 298(1):101495. PubMed ID: 34919964
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma.
Terai M; Shimada A; Chervoneva I; Hulse L; Danielson M; Swensen J; Orloff M; Wedegaertner PB; Benovic JL; Aplin AE; Sato T
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830903
[TBL] [Abstract][Full Text] [Related]
35. What's in a Name? Large Choroidal Nevus, Small Choroidal Melanoma, or Indeterminate Melanocytic Tumor.
Singh AD; Grossniklaus HE
Ocul Oncol Pathol; 2021 Sep; 7(4):235-238. PubMed ID: 34604194
[No Abstract] [Full Text] [Related]
36. Proteomics of Primary Uveal Melanoma: Insights into Metastasis and Protein Biomarkers.
Jang GF; Crabb JS; Hu B; Willard B; Kalirai H; Singh AD; Coupland SE; Crabb JW
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298739
[TBL] [Abstract][Full Text] [Related]
37. Uveal melanoma: Long-term survival.
Radivoyevitch T; Zabor EC; Singh AD
PLoS One; 2021; 16(5):e0250939. PubMed ID: 34003826
[TBL] [Abstract][Full Text] [Related]
38. Estimating Cured Fractions of Uveal Melanoma.
Singh AD; Zabor EC; Radivoyevitch T
JAMA Ophthalmol; 2021 Feb; 139(2):174-181. PubMed ID: 33355644
[TBL] [Abstract][Full Text] [Related]
39. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
